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Summary
Background.  —  Although  diabetes  is  associated  with  a  high  cardiovascular  risk,  very  little  infor-
mation is  available  about  diabetic  patients  enrolled  in  cardiac  rehabilitation  (CR).
Aims. —  To  analyse  the  characteristics  of  diabetic  patients  and  diabetes  care  in  CR.
Methods. —  From  the  database  of  700  patients  enrolled  in  CR  during  a  29-month  period,  we
analysed data  from  all  patients  with  glucose  metabolism  disorders  (n  =  105)  and  210  matched
normoglycaemic  patients.
Results.  —  A  total  of  105  patients  with  glucose  metabolism  disorders  (type  1  diabetes,  n  =  5;Glucose type 2  diabetes,  n  =  84;  impaired  fasting  glucose,  n  =  16)  were  enrolled  in  a  CR  programme
(15% of  whole  population).  Fifteen  per  cent  of  patients  with  type  2  diabetes  and  all  patients
with impaired  fasting  glucose  were  diagnosed  during  CR.  These  105  patients  were  older  and
had a  higher  body  mass  index,  a  larger  waist  circumference,  higher  fasting  blood  glucose  and
triglyceride  concentrations  and  lower  low-density  lipoprotein  cholesterol  concentrations  than
Abbreviations: ACE, acute coronary event; CR, cardiac rehabilitation; HbA1C, glycated haemoglobin; LDL, low-density lipoprotein; VO2,
oxygen consumption.
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non-diabetic  patients;  they  also  had  higher  rates  of  hypertension  (P  =  0.001)  and  dyslipidaemia
(P =  0.02).  They  were  more  frequently  referred  to  CR  for  peripheral  artery  disease  (P  =  0.001),
coronary  heart  disease  +  peripheral  artery  disease  (P  =  0.007)  and  primary  prevention  (P  =  0.009).
The intervention  of  a  diabetologist  was  needed  for  42.6%  of  patients  because  of  uncontrolled
or newly  diagnosed  diabetes.
Conclusion.  —  In  the  present  study,  we  showed  that  (1)  the  proportion  of  patients  with  diabetes
in CR  is  lower  than  expected,  (2)  many  glucose  metabolism  disorders  are  diagnosed  during  CR,
(3) patients  with  glucose  metabolism  disorders  show  a  more  severe  cardiovascular  risk  proﬁle
than normoglycemic  patients,  and  (4)  the  intervention  of  a  diabetologist  is  needed  during  CR
for many  patients  with  diabetes.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  Bien  que  le  diabète  soit  associé  à  un  risque  cardiovasculaire  élevé,  la  situation  des
patients  diabétiques  en  réadaptation  cardiaque  (RC)  reste  mal  connue.
Objectif.  —  Analyser  les  caractéristiques  des  patients  diabétiques  et  la  prise  en  charge  du
diabète en  RC.
Méthodes.  —  À  partir  d’une  base  de  données  de  700  patients  admis  en  RC  au  cours  d’une  période
de 29  mois,  nous  avons  étudié  les  données  de  tous  les  patients  avec  anomalies  du  métabolisme
glucidique  (n  =  105)  et  de  210  patients  normoglycémiques  appariés.
Résultats.  —  105  patients  avec  anomalies  du  métabolisme  glucidique  (5  diabète  de  type  1,
84 diabète  de  type  2,  16  hyperglycémies  à  jeun  non  diabétiques)  ont  été  admis  en  CR,  soit
15 %  de  l’ensemble  de  la  population.  Quinze  pour  cent  des  diabètes  de  type  2  et  toutes  les
hyperglycémies  à  jeun  non  diabétiques  ont  été  diagnostiqués  en  RC.  Ces  105  patients  étaient
plus âgés,  plus  hypertendus  et  présentaient  des  valeurs  plus  élevées  de  BMI,  tour  de  taille,  gly-
cémie à  jeun,  triglycérides  et  des  valeurs  plus  basses  de  LDL-cholestérol  comparés  aux  patients
non diabétiques.  Ils  étaient  plus  fréquemment  admis  en  RC  pour  artériopathie  des  membres
inférieurs (AMI)  (p  =  0,001),  coronaropathie  +  AMI  (p  =  0,007)  ou  prévention  primaire  (p  =  0,009).
Pour 42,6  %  des  patients,  l’intervention  d’un  diabétologue  fut  nécessaire  en  raison  de  mauvais
contrôle  du  diabète  ou  de  découverte  de  diabète.
Conclusion.  — Notre  étude  montre  que  :  (1)  la  proportion  des  patients  diabétiques  en  RC  est
plus faible  qu’attendu  ;  (2)  Plusieurs  anomalies  du  métabolisme  glucidique  sont  diagnostiquées
au cours  de  la  RC  ;  (3)  les  patients  avec  anomalies  du  métabolisme  glucidique  admis  en  RC
ont proﬁl  cardiovasculaire  plus  sévère  que  les  non  diabétiques  ;  et  (4)  que  l’intervention  d’un
diabétologue  au  cours  de  la  RC  est  nécessaire  pour  de  nombreux  patients  diabétiques.
© 2014  Elsevier  Masson  SAS.  Tous  droits  réservés.
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iabetic  patients  are  at  increased  risk  of  coronary  heart
isease,  heart  failure  and  stroke.  Cardiovascular  disease
n  diabetic  patients  is  also  more  severe,  with  signiﬁcantly
igher  rates  of  morbidity  and  mortality  compared  to
ardiovascular  patients  without  diabetes  [1,2].  Several
tudies  have  clearly  shown  that  cardiac  rehabilitation  (CR)
igniﬁcantly  reduces  cardiovascular  morbidity  and  mortality
nd  improves  quality  of  life  [3—5].  The  ﬁrst  meta-analyses
learly  demonstrated  that  CR  after  myocardial  infarction
igniﬁcantly  reduced  cardiovascular  morbidity  and  mortality
3,4,6].  This  clear  beneﬁcial  effect  of  CR  on  overall  mortal-
ty  and  cardiovascular  mortality  was  conﬁrmed  subsequently
y  several  clinical  trials  [7,8]  and  meta-analyses  [5,9,10].
he  cardiovascular  mortality  rate  in  patients  who  underwent
R  with  exercise  training  after  myocardial  infarction  was
ound  to  be  20—26%  lower  than  in  those  who  did  not  have  CR
3,4,10].  Long-term  reductions  in  cardiovascular  mortality
nd  total  mortality  after  CR  were  conﬁrmed  by  Hedbäck
b
p
tt  al.,  who  showed  a  26.7%  reduction  in  total  mortality  and
 27.1%  reduction  in  cardiovascular  mortality  over  a  10-year
eriod  [11].  Hence,  CR  programmes  are  recognized  as  an
ntegral  part  of  the  care  strategy  for  patients  with  coronary
eart  disease,  heart  failure,  cardiac  surgery  and  peripheral
rtery  disease,  and  CR  is  a  level  A  recommendation  in
atients  with  coronary  heart  disease  [12—17].
CR  is  strongly  recommended  for  both  primary  and  sec-
ndary  prevention  in  patients  with  type  2  diabetes  because
f  their  high  cardiovascular  risk.  However,  little  is  known
bout  diabetic  patients  who  undergo  CR.  For  instance,  it  is
ot  clearly  known  whether  diabetic  patients  referred  for  CR
re  representative  of  all  diabetic  individuals  and  whether
here  are  differences  compared  with  non-diabetic  patients
eferred  for  CR.  In  addition,  there  are  no  data  on  gly-
aemic  control  during  CR,  and  the  percentage  of  patients
ho  are  referred  to  a  diabetologist  for  uncontrolled  dia-
etes  is  unknown.  This  lack  of  knowledge  prompted  us  to
erform  a  retrospective  study  to  analyse  the  characteris-
ics  of  diabetic  patients  enrolled  in  CR,  including  clinical
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sDiabetic  patients  and  diabetes  care  in  cardiac  rehabilitation
and  biological  features,  cardiovascular  complications,  other
diabetes-related  complications,  indications  for  CR,  diabetes
care  in  CR  and  situations  in  which  referral  to  a  diabetologist
was  needed.
Methods
Patients
From  the  database  of  the  700  patients  enrolled  in  a  com-
prehensive  CR  programme  in  a  CR  centre  (clinique  des
Rosiers,  Dijon)  from  September  2008  to  February  2011,
we  retrospectively  reviewed  data  from  all  patients  with
diabetes  or  fasting  hyperglycaemia  (n  =  105).  In  addition,
for  each  patient  with  a  glucose  metabolism  disorder  (dia-
betes  or  fasting  hyperglycaemia),  we  selected,  by  drawing
lots,  two  normoglycaemic  patients  enrolled  in  the  same  CR
programme  during  the  same  month,  in  order  to  have  a  ran-
domized  control  group  of  210  individuals.
All  of  the  patients  were  enrolled  in  an  outpatient  CR
programme  consisting  of  20  physical  training  sessions,  an
individualized  educational  programme  (nutrition,  manage-
ment  and  control  of  cardiovascular  risk  factors  to  reach  the
goals  of  secondary  prevention,  stress  management,  smoking
cessation),  psychological  support,  and  help  with  occupa-
tional  and  work  reintegration.
During  the  programme,  all  patients  had  a  regular  car-
diac  follow-up  (once  a  week),  to  assess  cardiac  treatment,
patient  motivation  and  cardiovascular  risks  factors,  and
to  supervise  training  sessions.  A  multidisciplinary  meet-
ing  was  held  each  week.  Diabetic  patients  had  a  careful
follow-up  that  included  blood  glucose  monitoring  during
training  sessions,  modiﬁcations  of  antidiabetic  treatments
when  needed,  a  speciﬁc  group  educational  course  and  nutri-
tional  counselling.
Data collection
For  all  of  the  patients,  we  collected  baseline  clinical  and  bio-
logical  characteristics,  indications  for  CR  and  cardiovascular
risk  factors  (hypertension,  smoking,  dyslipidaemia).  Patients
were  considered  dyslipidaemic  when  plasma  low-density
lipoprotein  (LDL)-cholesterol  or  triglyceride  concentrations
were  above  the  recommended  target  or  when  they  were  tak-
ing  hypolipidaemic  agents.  Data  on  diabetes,  including  type
of  diabetes,  duration  of  diabetes,  treatment,  complications
and  need  to  be  referred  to  a  diabetologist  during  the  CR
programme,  were  also  collected.
Coronary  heart  disease  was  deﬁned  as  the  occurrence
of  an  acute  coronary  event  (ACE),  angina  pectoris,  the
presence  of  coronary  artery  occlusion  on  the  coronary
angiogram,  percutaneous  coronary  intervention  with  stent
placement,  or  coronary  artery  bypass  surgery.  Peripheral
artery  disease  was  deﬁned  as  the  presence  of  intermittent
claudication,  a  history  of  limb  artery  surgery,  or  an  abnormal
lower  limb  Doppler  ultrasound  scan.Statistical analysis
Data  are  expressed  as  mean  ±  standard  deviations  for
quantitative  variables  and  as  percentages  for  qualitative
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ariables.  The  two  populations  were  compared  using  the
hi2 test  for  qualitative  variables  and  Student’s  t  test  for
uantitative  variables.  A  P  value  <  0.05  was  considered  sta-
istically  signiﬁcant.  Statistical  calculations  were  performed
sing  the  SPSS  software  package  (Chicago,  IL,  USA).
esults
linical and biological characteristics and
ardiovascular risk factors
uring  the  29-month  study  period,  105  patients  with  glucose
etabolism  disorders  (22  women  and  83  men)  were  enrolled
n  the  CR  programme.  This  number  represented  15%  of  the
hole  population  (n  =  700)  enrolled  in  CR  during  the  same
eriod.
The  105  patients  with  glucose  metabolism  disorders
ncluded  ﬁve  patients  with  type  1  diabetes  (5%),  84  patients
ith  type  2  diabetes  (80%)  and  16  patients  with  impaired
asting  glucose  (15%).  Among  the  84  patients  with  type  2
iabetes,  13  were  diagnosed  with  type  2  diabetes  (15%)  dur-
ng  the  CR.  All  of  the  patients  with  impaired  fasting  glucose
ere  diagnosed  during  the  CR.  Among  the  105  patients  with
lucose  metabolism  disorders,  29  (27.6%)  were  diagnosed
uring  the  CR.
The  105  patients  with  glucose  metabolism  disorders  were
ompared  with  210  normoglycaemic  patients  (54  women
nd  156  men)  enrolled  in  the  CR  programme,  during  the
ame  period  (ratio  1:2).  The  main  characteristics  of  the
atients  with  glucose  metabolism  disorders  and  normogly-
aemic  patients  are  shown  in  Table  1.  Patients  with  glucose
etabolism  disorders  were  older  than  normoglycaemic
atients  (63.31  ±  12.38  vs.  60.92  ±  9.87  years;  P  =  0.038)  and
ad  a  higher  body  mass  index  and  waist  circumference.
hey  also  had  higher  fasting  blood  glucose  and  triglyceride
oncentrations,  lower  LDL-cholesterol  concentrations  and
 more  severe  cardiovascular  risk  proﬁle,  with  a  greater
roportion  of  patients  with  hypertension  (P  =  0.001)  and
yslipidaemia  (P  =  0.02).  Patients  with  glucose  metabolism
isorders  had  a  lower  baseline  cycloergometer  workload
han  normoglycaemic  patients.
eferral to cardiac rehabilitation
ndications  for  CR  are  shown  in  Table  2.  Patients  with  glu-
ose  metabolism  disorders  were  more  frequently  referred
or  CR  for  peripheral  artery  disease  (P  =  0.001),  coronary
eart  disease  +  peripheral  artery  disease  (P  =  0.007),  and  pri-
ary  prevention  (P  =  0.009)  compared  with  normoglycaemic
atients.
The  type  of  medical  doctor  (cardiologist,  heart  sur-
eon,  other  medical  doctor)  who  referred  patients  for  CR
as  similar  for  patients  with  glucose  metabolism  disorders
nd  normoglycaemic  patients.  Most  patients  were  referred
y  cardiologists  (74%  of  patients  with  glucose  metabolism
isorders  and  72%  of  normoglycaemic  patients)  or  heart
urgeons  (19%  of  patients  with  glucose  metabolism  dis-
rders  and  25%  of  normoglycaemic  patients).  The  other
edical  doctors  who  referred  patients  for  CR  were  general
ractitioners,  diabetologists,  nephrologists  and  angiolo-
ists.
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Table  1  Main  clinical  and  biological  characteristics  and  risk  factors.
Normoglycaemic
patients
(n  =  210)
Patients  with  glucose
metabolism  disorders
(n  =  105)
P
Age  (years)  60.92  ±  9.87  63.31  ±  12.38  0.038
Men  156  (74.3) 83  (79.0)  0.35
Weight  (kg) 78.97  ±  15.61 87.53  ±  15.10 <  0.001
Height  (cm) 168.94  ±  14.18 169.21  ±  9.85 0.86
BMI  (kg/m2)  28.53  ±  13.38  29.96  ±  5.01  0.29
Waist  circumference  (cm)  97.96  ±  11.25  107.25  ±  13.25  <  0.001
Fasting  blood  glucose  (mmol/L)  5.27  ±  0.50  7.49  ±  2.11  <  0.001
Total  cholesterol  (mmol/L)  4.26  ±  1.11  4.13  ±  1.08  0.37
LDL-cholesterol  (mmol/L)  2.43  ±  0.95  2.17  ±  0.77  0.01
HDL-cholesterol  (mmol/L)  1.21  ±  0.36  1.14  ±  0.28  0.10
Triglycerides  (mmol/L)  1.37  ±  0.70  1.92  ±  1.86  0.005
Creatinine  (mol/L)  92.75  ±  47.61  88.61  ±  22.38  0.40
Hypertension  124  (59)  82  (78)  0.001
Dyslipidaemia  180  (86)  99  (94)  0.02
Tobacco  smoking  50  (24)  23  (22)  0.71
Statin  treatment  201  (96)  100  (95)  0.85
ACEI/ARB  treatment  184  (88)  95  (90)  0.45
Beta-blocker  treatment  176  (84)  87  (83)  0.83
Antiplatelet  agent  treatment  210  (100)  105  (100)  1
Cycloergometer  peak  workload  (W)  94  ±  32  83  ±  28  0.002
Data are mean ± standard deviation or number (%). ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin II receptor blocker;
BMI: body mass index: HDL: high-density lipoprotein; LDL: low-density lipoprotein.
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Aiabetic complications in patients enrolled in
ardiac rehabilitation
s  far  as  microvascular  complications  were  concerned,  5%
f  the  diabetic  patients  had  retinopathy,  21%  had  nephropa-
hy  and  17%  had  neuropathy.  In  terms  of  macrovascular
omplications,  91%  of  the  diabetic  patients  had  coronary
eart  disease  and  30%  had  peripheral  artery  disease.
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Table  2  Indications  for  cardiac  rehabilitation.
Normog
patient
Indication,  n  (%)  (n  =  210
Coronary  heart  disease  165  (78.
Stable  angina  46  (21.
Acute  coronary  event  94  (44.
Asymptomatic  25  (11.
Stent(s)  102  (48.
Coronary  artery  bypass  surgery  57  (27.
Coronary  heart  disease  +  peripheral  artery  disease  10  (4.8
Coronary  heart  disease  +  aortic  valve  replacement  8  (3.8
Aortic  valve  replacement  25  (11.
Peripheral  artery  disease  16  (7.6
Dilated  cardiomyopathy  14  (6.7
Mitral  valve  replacement 10  (4.8
Cardiac  rhythm  disorder  17  (8.1
Primary  prevention  1  (0.5
Congenital  heart  disease  3  (1.4reatment of diabetes at time of enrolment in
ardiac rehabilitation
ntidiabetic  treatment  at  time  of  enrolment  in  the  CR  pro-
ramme  in  patients  with  diabetes  is  shown  in  Fig.  1: 18%
f  patients  had  no  antidiabetic  treatment,  45%  had  oral
ntidiabetic  drugs  (OADs)  only,  18%  had  an  OAD  plus  insulin
ombination,  18%  had  basal-bolus  insulin  therapy,  and  1%
lycaemic
s
Patients  with  glucose
metabolism  disorders
P
)  (n  =  105)
5)  81  (77.1)  0.85
9)  31  (29.5)  0.14
7)  33  (31.4)  0.02
9)  17  (16.2)  0.29
5)  51  (48.5)  1
1)  28  (26.6)  0.92
)  14  (13.3)  0.007
)  6  (5.7)  0.85
9)  10  (9.5)  0.52
)  21  (20.0)  0.001
)  5  (4.8)  0.50
)  2  (1.9)  0.21
)  7  (6.7)  0.65
)  5  (4.8)  0.009
)  0  (0)  0.22
Diabetic  patients  and  diabetes  care  in  cardiac  rehabilitation  
Figure 1. Antidiabetic treatments at referral and at discharge
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ofrom cardiac rehabilitation (CR) programme. GLP-1: glucagon-like
peptide 1 analogue; OAD: oral antidiabetic drug.
had  an  OAD  plus  glucagon-like  peptide  1  analogue  combina-
tion.
Referral to  a diabetologist during cardiac
rehabilitation
During  CR,  the  intervention  of  a  diabetologist  was  needed  for
42.6%  of  the  patients  with  diabetes.  A  patient  with  diabetes
was  referred  to  a  diabetologist  when  diabetes  was  diag-
nosed  during  CR  and  in  situations  of  uncontrolled  diabetes
(glycated  haemoglobin  [HbA1C]  ≥  7.05%)  and/or  frequent
hypoglycaemic  events.  This  intervention  took  the  form  of
telephone  advice  in  12.3%  of  patients,  a  consultation  in
13.5%  of  patients,  a  1-day  outpatient  hospitalization  in  the
diabetology  department  for  12.3%  of  patients  and  inpatient
hospitalization  in  the  diabetology  department  for  several
days  for  4.5%  of  patients  (Fig.  2).Mean  HbA1C according  to  the  type  of  intervention  by  the
diabetologist  is  also  shown  in  Fig.  2.  Mean  HbA1C was  sig-
niﬁcantly  higher  in  diabetic  patients  for  whom  specialized
Figure 2. Referral to a diabetologist during cardiac rehabilitation
and mean glycated haemoglobin (HbA1C).
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dvice  was  needed:  7.71%  vs.  6.83%  (P  <  0.001).  Mean  HbA1C
as  not  very  high  (6.99%)  in  patients  who  were  hospital-
zed  for  one  day.  However,  most  of  these  patients  had  newly
iagnosed  diabetes,  which  explains  why  the  mean  HbA1C was
nly  moderately  high.  For  these  patients  with  newly  diag-
osed  diabetes,  the  1-day  hospitalization  was  organized  to
erform  a complete  check-up  for  diabetes  complications  and
lso  for  educational  purposes.
reatment of diabetes at discharge from
ardiac rehabilitation programme
or  patients  with  diabetes,  antidiabetic  treatment  at  dis-
harge  from  the  CR  programme  is  shown  in  Fig.  1.  The
ercentage  of  patients  receiving  antidiabetic  treatment  at
he  end  of  the  CR  programme  was  signiﬁcantly  higher  than
t  the  beginning  of  CR  (92%  vs.  82%;  P  =  0.04).
iscussion
R  is  recognized  as  an  integral  part  of  the  care  strategy
or  patients  with  coronary  heart  disease,  heart  failure  and
eripheral  artery  disease,  and  for  those  who  have  undergone
ardiac  surgery.  Although  cardiovascular  disease  is  the  main
ause  of  mortality  in  diabetic  patients,  very  few  data  are
vailable  for  patients  with  diabetes  enrolled  in  CR.
Our  present  study  is  the  ﬁrst  to  show  the  clinical  and
iological  characteristics  of  diabetic  patients  enrolled  in  a
R  programme,  the  indications  for  CR,  diabetes  care  in  CR
nd  the  situations  for  which  referral  to  a  diabetologist  is
eeded.
First  of  all,  the  percentage  of  patients  with  glucose
etabolism  disorders  referred  for  CR  is  low.  Indeed,  105
atients  with  diabetes  (n  =  89)  or  impaired  fasting  glucose
n  =  16)  were  included  in  our  study.  This  represented  only  15%
f  patients  referred  for  CR  during  the  same  period.  When
onsidering  only  patients  with  diabetes,  they  accounted  for
nly  12%  of  patients  referred  for  CR.  This  proportion  of
atients  with  diabetes  in  CR  is  very  low  and  much  lower
han  expected  given  the  high  percentage  of  patients  with
iabetes  hospitalized  for  ACEs.  Indeed,  in  a  study  conducted
n  999  patients  hospitalized  for  ACEs,  Zeller  et  al.  showed
hat  53%  had  metabolism  disorders  (38%  with  diabetes  and
5%  with  impaired  fasting  glucose)  [18].  Our  data  showing
 low  rate  of  patients  with  diabetes  in  CR  are  in  accor-
ance  with  several  other  studies.  For  instance,  Jeger  et  al.,
rom  a  population  of  1061  patients  referred  for  CR  during
 4-year  period,  reported  only  15%  of  patients  with  dia-
etes  [19]. Suresh  et  al.  reported  that  among  1804  patients
ho  attended  CR  during  10  years,  only  12.4%  had  diabetes
20]. Hindman  et  al.  reported  that  among  the  1505  patients
ho  attended  their  CR  programme,  19%  had  diabetes  [21].
nalysing  the  large  Medicare  database,  Suaya  et  al.  reported
hat  the  proportion  of  patients  with  diabetes  was  low  [22].
oth  Suaya  et  al.  and  Dunlay  et  al.  demonstrated  that
iabetes  was  associated  with  a  signiﬁcant  lower  rate  of
ttendance  at  a  CR  programme  [22,23].  In  a  study  by  Dun-
ay  et  al.,  the  absence  of  diabetes  increased  the  referral
ate  for  CR  by  a  factor  of  2.5  [23], which  is  in  line  with
ur  present  results.  It  has  also  been  shown  that  other  pop-
lations,  such  as  women,  elderly  patients  and  patients  with
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ultiple  comorbidities,  are  less  likely  to  be  referred  for  CR
22].  Several  studies  have  shown  that  the  support  of  car-
iologists  is  essential  for  referral  for  CR  [23—25].  We  may
uppose  that  some  cardiologists,  who  are  the  main  pre-
cribers  of  CR,  might  consider  that  CR  is  not  suitable  for
xtremely  fragile  patients,  including  patients  with  diabetes.
owever,  it  has  been  shown  that  all  populations,  including
he  more  fragile  patients,  beneﬁt  from  CR  [26].  Our  group
as  previously  shown  that  CR  is  also  effective  in  patients
ith  diabetes  and  that  improvement  in  oxygen  consumption
VO2)  after  CR  is  inversely  associated  with  HbA1C [27]. The
irect  effect  of  strict  glycaemic  control  on  VO2 improve-
ent  after  CR  in  patients  with  type  2  diabetes  after  an  ACE
s  presently  being  investigated  in  the  DARE  study.  In  addi-
ion,  as  previously  reported  by  others  [28—31],  our  diabetic
atients  enrolled  in  CR  carried  a  high  cardiovascular  risk
nd  included  a  higher  proportion  of  patients  with  hyperten-
ion  and  dyslipidaemia.  This  reinforces  the  fact  that  patients
ith  diabetes,  who  have  a  high  cardiovascular  risk,  are  well
uited  to  CR.
Another  interesting  point  is  the  fact  that  27.6%  of
atients  with  abnormal  glucose  disorders  were  diagnosed
uring  CR,  including  all  of  the  patients  with  impaired
asting  glucose  and  15%  of  the  patients  with  type  2  dia-
etes.  Newly  detected  abnormal  glucose  tolerance  has  been
eported  to  be  a  strong  independent  risk  factor  for  mor-
ality  and  morbidity  after  myocardial  infarction  [32]. Thus,
t  seems  important  to  detect  such  abnormal  glucose  disor-
ers,  including  impaired  fasting  glucose,  after  any  coronary
vent.  This  indicates  that  CR  programmes  provide  an  excel-
ent  opportunity  to  diagnose  glucose  metabolism  disorders
n  patients  with  cardiovascular  disease.  The  diagnosis  of
lucose  metabolism  disorders  is  not  always  made  during
ospitalization  for  an  ACE  [33].  It  is  for  this  reason  that
ecent  Société  franc¸aise  du  diabète  (SFD)/Société  franc¸aise
e  cardiologie  (SFC)  guidelines  recommend  performing  an
ral  glucose  tolerance  test  between  week  1  and  week  4  after
he  ACE  [34].  As  CR  often  starts  during  the  month  following
he  ACE,  we  think  that  the  CR  period  may  provide  a good
pportunity  to  perform  the  oral  glucose  tolerance  test.
Regarding  the  indications  for  CR,  we  found  some  signiﬁ-
ant  differences  between  patients  with  glucose  metabolism
isorders  and  normoglycaemic  patients.  Indeed,  diabetic
atients  are  more  frequently  referred  for  CR  for  peripheral
rtery  disease  and  coronary  heart  disease  plus  periph-
ral  artery  disease.  Once  again,  these  data  underline  the
igh  frequency  of  the  multiple  vascular  disorders  in  dia-
etic  patients.  Interestingly,  we  showed  that  patients  with
etabolism  disorders  are  more  frequently  referred  for  CR
or  primary  prevention.  This  may  suggest  that  cardiologists,
iabetologists  and  general  practitioners  are  becoming  aware
f  the  beneﬁts  of  CR  for  primary  prevention  in  diabetes.
In  the  present  study,  we  showed  that  the  intervention  of
 diabetologist  was  needed  during  CR  for  more  than  40%
f  the  patients  with  diabetes  because  of  uncontrolled  or
ewly  diagnosed  diabetes.  This  ﬁnding  emphasizes  the  need
or  collaboration  between  diabetologists  and  cardiologists
nvolved  in  CR,  as  recommended  by  the  recent  ‘consensus
tatement  on  care  of  the  hyperglycaemic/diabetic  patient
uring  and  in  the  immediate  follow-up  of  an  acute  coronary
yndrome’  by  the  SFD/SFC  [34].  In  our  present  study,  the
fﬁcacy  of  the  collaboration  between  cardiologists  involvedM.  Beacco  et  al.
n  CR  and  diabetologists  is  underlined  by  the  fact  that  sig-
iﬁcantly  more  patients  with  diabetes  had  an  antidiabetic
reatment  at  the  end  of  CR  programme  than  at  the  begin-
ing.
One  limitation  of  the  present  study  is  that  it  is  a  single-
entre  study  and  the  results  might  not  be  entirely  applicable
o  other  institutions.
onclusions
he  number  of  patients  with  diabetes  referred  for  CR  was
uch  lower  than  expected  in  our  study,  and  these  patients
ad  a  more  severe  cardiovascular  risk  proﬁle  than  normogly-
aemic  patients  enrolled  in  CR.  We  also  showed  that  many
lucose  metabolism  disorders  are  diagnosed  during  CR  and
hat  the  intervention  of  a  diabetologist  is  needed  during  CR
or  more  than  40%  of  the  patients  with  diabetes.  Cardiolo-
ists  involved  in  CR  have  the  opportunity  to  diagnose  glucose
etabolism  disorders  (including  diabetes)  and  offer  patients
he  most  effective  management  through  a  beneﬁcial  collab-
ration  with  diabetologists.
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